Dendrite
Clinical Systems
Latest News

Quick Enquiry

Name:

E-mail:

Enquiry:

08 January 2013
Dendrite launches Real World Evidence service

Dendrite Clinical Systems is pleased to announce that the company has launched an innovative Real World Evidence (RWE) service to assist pharmaceutical and medical device companies in collecting and generating scientifically robust data about their product safety and effectiveness in real clinical practice.


RWE is an emerging powerful trend which is becoming a cornerstone of value-based pricing and may redefine the basis of competition and access in the pharmaceutical and medical device industry in the near future.


RWE goes beyond traditional controlled clinical trials. Pharmaceutical and medical device companies can use RWE data to inform stakeholders about a product"s use, treatment patterns (standards of care), benefits and cost effectiveness to gain and defend market access, inform the design of products and trials and transform their relationships with clinicians from a supplier to a collaborator.


Large scale RWE data has not been available until recently - this is a major opportunity to demonstrate the value of pharma and medical device products. Dendrite has had an increasing number of companies enquiring about RWE data.


All of the major pharmaceutical companies have recently initiated RWE projects to inform product development and/or commercial decisions. Post market research has been one of the few growing area in the clinical research field in recent years. Indeed, if pharmaceutical and medical device companies do not take the initiative and lead the development of compelling real world cost-effectiveness arguments, regulatory agencies will create their own potentially unfavourable product narratives of which we have seen multiple examples already.


While there may be various sources of real world clinical information (such as Electronic Patient Record systems), implementation experience has proven that this information is mostly sporadic, incomplete and difficult to reconcile and analyse, particularly on a large scale. Clinical registries have proven to be the main source of scientifically robust large scale RWE to date.

Dendrite Clinical Systems is a global leader in the area of clinical registries with an extensive experience in the field of RWE studies. Our customer dedication and delivery track record is impeccable. The company would be delighted to work with you to help you design and support your RWE project.

If you are interested in discussing a Real World Evidence project, please contact:


Alexey Brovko

Tel: 00 44 2089498999

email: alexey.brovko@e-dendrite.com